Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Terminated × fezolinetant × Clear all

Phase

Status

Recruiting 2 Terminated 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Intraductal, Noninfiltrating 1

Interventions

Cyclophosphamide 143 Docetaxel 134 Carboplatin 131 Bevacizumab 131 pembrolizumab 127 Radiotherapy 120 Gemcitabine 119 Cisplatin 118 Paclitaxel 114 Capecitabine 106 Rituximab 100 Fluorouracil 94 Oxaliplatin 89 Nivolumab 77 Irinotecan 77 Leucovorin 75 Doxorubicin 73 Dexamethasone 70 Pemetrexed 68 fludarabine 64 fludarabine phosphate 61 Etoposide 61 Bortezomib 58 Erlotinib Hydrochloride 56 Methotrexate 53 Cetuximab 53 Cytarabine 52 Trastuzumab 49 Lenalidomide 45 Filgrastim 44

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06617455 2026-03-02

VEnT

University of Michigan Rogel Cancer Center

Phase 2 Terminated

Carcinoma, Intraductal, Noninfiltrating

Data powered by HemOnc (CC BY 4.0) Colophon ⚡